These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10528586)

  • 1. [Can we really reach our goals? Arguments for aggressive lipid lowering].
    Internist (Berl); 1999 Sep; 40(9 Suppl Argumente):1-8. PubMed ID: 10528586
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating lipid-lowering trials in the twenty-first century.
    Roberts WC
    Am J Cardiol; 2009 May; 103(9):1325-8. PubMed ID: 19406281
    [No Abstract]   [Full Text] [Related]  

  • 3. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the dose-response curve of a new hypolipidemic molecule: tibric acid (CP-18524). Methodologic and statistical aspects].
    Bielmann P; Annable L; Brun D; Moorjani S; Lupien PJ; Tétreault L
    Union Med Can; 1975 Jun; 104(6):930-4. PubMed ID: 1224412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Type 2 diabetic patients. Aggressive management of increased blood lipids].
    MMW Fortschr Med; 2000 May; 142(20):64. PubMed ID: 10870401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation with a new drug lowering blood lipids (Tiadenol)].
    Potì R; Quintavalla R; Manotti C
    G Clin Med; 1977; 58(7-8):293-300. PubMed ID: 336442
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary revascularization and aggressive lipid lowering.
    Pershad A; Kratzer S; Cooper A
    J Invasive Cardiol; 1999 Feb; 11(2):87-9. PubMed ID: 10745488
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperlipidemia: treatment with lipid-lowering agents.
    LaRosa JC
    Md Med J; 1988 May; 37(5):401-6. PubMed ID: 3386426
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for lipid disorders.
    Treat Guidel Med Lett; 2003 Aug; 1(12):77-82. PubMed ID: 15529095
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipid-lowering drugs].
    Fortschr Med Suppl; 1988; 46():13-4. PubMed ID: 2905325
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-lowering drugs: French prescribers under pressure.
    Prescrire Int; 2002 Oct; 11(61):158. PubMed ID: 12378750
    [No Abstract]   [Full Text] [Related]  

  • 12. [New drug against lipid disorders. HDL level rises 30%].
    MMW Fortschr Med; 2003 Sep; 145(39):51. PubMed ID: 14649076
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement in current approaches to lipid lowering.
    Ansell BJ
    Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation of the use of lipid-lowering medications prior to percutaneous coronary intervention to the incidence of intraprocedural adverse angiographic events.
    Ferguson MA; Romick BG; Carter LI; De Geare VS
    Am J Cardiol; 2005 Apr; 95(8):978-80. PubMed ID: 15820168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving lipid goals in Europe: how large is the treatment gap?
    Schwandt P; Brady AJ
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):431-49. PubMed ID: 15151488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MPPG complex belongs in the first phase of drug-assisted lipid lowering (magnesium-pyridoxal-phosphate-glutamate )].
    Wieland H
    Fortschr Med; 1990; 108 Spec No 1():52-3. PubMed ID: 2245961
    [No Abstract]   [Full Text] [Related]  

  • 17. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering.
    Wilcock M
    Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882
    [No Abstract]   [Full Text] [Related]  

  • 18. Statin use in a "real-world" clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial.
    Koren MJ
    Am J Med; 2005 Dec; 118 Suppl 12A():16-21. PubMed ID: 16356803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for lipid-lowering therapy. Results of the 2d Consensus Conference of the European Atherosclerosis Society. Press conference. London, 6 May 1988].
    Fortschr Med Suppl; 1988; 46():1-22. PubMed ID: 2905324
    [No Abstract]   [Full Text] [Related]  

  • 20. Three new drugs for hyperlipidemia.
    Conn Med; 2003 May; 67(5):279-81. PubMed ID: 12802842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.